The Food and Drug Administration warned that insulin pumps manufactured by Medtronic in 2012 may bring potential cybersecurity and health risks to patients, Nextgov reported Friday. According to a separate statement, other
We use cookies to offer you a better browsing experience, analyze site traffic, personalize content, and serve targeted advertisements. Read about how we use cookies and how you can control them on our Privacy Policy. If you continue to use this site, you consent to our use of cookies.